Artificial Intelligence-Based Opportunities in Liver Pathology-A Systematic Review.

artificial intelligence deep learning digital pathology hepatology liver performance metrics

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
19 May 2023
Historique:
received: 05 04 2023
revised: 04 05 2023
accepted: 12 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Artificial Intelligence (AI)-based Deep Neural Networks (DNNs) can handle a wide range of applications in image analysis, ranging from automated segmentation to diagnostic and prediction. As such, they have revolutionized healthcare, including in the liver pathology field. The present study aims to provide a systematic review of applications and performances provided by DNN algorithms in liver pathology throughout the Pubmed and Embase databases up to December 2022, for tumoral, metabolic and inflammatory fields. 42 articles were selected and fully reviewed. Each article was evaluated through the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool, highlighting their risks of bias. DNN-based models are well represented in the field of liver pathology, and their applications are diverse. Most studies, however, presented at least one domain with a high risk of bias according to the QUADAS-2 tool. Hence, DNN models in liver pathology present future opportunities and persistent limitations. To our knowledge, this review is the first one solely focused on DNN-based applications in liver pathology, and to evaluate their bias through the lens of the QUADAS2 tool.

Sections du résumé

BACKGROUND BACKGROUND
Artificial Intelligence (AI)-based Deep Neural Networks (DNNs) can handle a wide range of applications in image analysis, ranging from automated segmentation to diagnostic and prediction. As such, they have revolutionized healthcare, including in the liver pathology field.
OBJECTIVE OBJECTIVE
The present study aims to provide a systematic review of applications and performances provided by DNN algorithms in liver pathology throughout the Pubmed and Embase databases up to December 2022, for tumoral, metabolic and inflammatory fields.
RESULTS RESULTS
42 articles were selected and fully reviewed. Each article was evaluated through the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool, highlighting their risks of bias.
CONCLUSIONS CONCLUSIONS
DNN-based models are well represented in the field of liver pathology, and their applications are diverse. Most studies, however, presented at least one domain with a high risk of bias according to the QUADAS-2 tool. Hence, DNN models in liver pathology present future opportunities and persistent limitations. To our knowledge, this review is the first one solely focused on DNN-based applications in liver pathology, and to evaluate their bias through the lens of the QUADAS2 tool.

Identifiants

pubmed: 37238283
pii: diagnostics13101799
doi: 10.3390/diagnostics13101799
pmc: PMC10217251
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Cells. 2020 Mar 11;9(3):
pubmed: 32168869
Mod Pathol. 2021 Feb;34(2):417-425
pubmed: 32948835
Lancet Digit Health. 2019 Oct;1(6):e271-e297
pubmed: 33323251
Ann Surg Oncol. 2020 Jul;27(7):2359-2369
pubmed: 31916093
Nat Commun. 2020 Aug 27;11(1):4294
pubmed: 32855423
Am J Pathol. 2022 Mar;192(3):553-563
pubmed: 34896390
Front Physiol. 2022 Oct 14;13:994304
pubmed: 36311222
Comput Med Imaging Graph. 2021 Jun;90:101923
pubmed: 33894669
Lancet Oncol. 2020 Feb;21(2):222-232
pubmed: 31926806
Liver Int. 2020 Sep;40(9):2050-2063
pubmed: 32515148
Hepatology. 2021 Jun;73(6):2546-2563
pubmed: 33098140
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
J Gastroenterol Hepatol. 2021 Mar;36(3):539-542
pubmed: 33709605
World J Gastroenterol. 2021 Oct 7;27(37):6191-6223
pubmed: 34712027
Sci Rep. 2021 Jan 21;11(1):2047
pubmed: 33479370
Cancers (Basel). 2021 Jul 01;13(13):
pubmed: 34282750
J Hepatol. 2022 May;76(5):1030-1041
pubmed: 35090960
Gut. 2021 Jun;70(6):1183-1193
pubmed: 33214163
Radiology. 2020 Apr;295(1):4-15
pubmed: 32068507
Artif Intell Med. 2022 Mar;125:102244
pubmed: 35241257
Sci Rep. 2019 Dec 5;9(1):18454
pubmed: 31804575
Transl Lung Cancer Res. 2020 Oct;9(5):2255-2276
pubmed: 33209648
Comput Biol Med. 2022 Sep 6;150:106089
pubmed: 36137315
BMJ. 2021 Mar 15;372:n304
pubmed: 33722847
Biomolecules. 2021 Dec 02;11(12):
pubmed: 34944452
Gastroenterology. 2022 Jun;162(7):1948-1961.e7
pubmed: 35202643
Front Oncol. 2022 Aug 19;12:968202
pubmed: 36059627
Sci Rep. 2021 Jan 8;11(1):139
pubmed: 33420322
Hepatology. 2020 Dec;72(6):2000-2013
pubmed: 32108950
Dig Liver Dis. 2022 Mar;54(3):299-308
pubmed: 34266794
Proc IEEE Int Symp Biomed Imaging. 2019 Apr;2019:24-27
pubmed: 32670464
Phys Med. 2021 Mar;83:9-24
pubmed: 33662856
Sensors (Basel). 2021 Mar 12;21(6):
pubmed: 33808978
NPJ Precis Oncol. 2020 Jun 8;4:14
pubmed: 32550270
Ann Diagn Pathol. 2020 Aug;47:151518
pubmed: 32531442
Assay Drug Dev Technol. 2020 Jan;18(1):1-10
pubmed: 31149832
Comput Biol Med. 2022 Jul;146:105520
pubmed: 35537220
Front Oncol. 2022 Oct 06;12:1005805
pubmed: 36276163
Front Oncol. 2022 Apr 01;12:844067
pubmed: 35433467
J Med Imaging Radiat Sci. 2019 Dec;50(4 Suppl 2):S32-S41
pubmed: 31447230
Lab Invest. 2020 Oct;100(10):1367-1383
pubmed: 32661341
Diagn Pathol. 2021 May 6;16(1):41
pubmed: 33957930
Comput Biol Med. 2017 May 1;84:156-167
pubmed: 28365546
Hum Pathol. 2015 May;46(5):767-75
pubmed: 25776030
J Hepatol. 2020 Dec;73(6):1322-1332
pubmed: 32610115
Nat Med. 2021 Oct;27(10):1663-1665
pubmed: 34635854
Oncology (Williston Park). 2022 Aug 10;36(8):492-498
pubmed: 36001788
Front Oncol. 2021 Dec 01;11:762733
pubmed: 34926264
Cytometry B Clin Cytom. 2019 Nov;96(6):521-528
pubmed: 31173462
Hum Pathol. 2014 Apr;45(4):785-92
pubmed: 24565203
NPJ Digit Med. 2020 Feb 26;3:23
pubmed: 32140566
BMJ Health Care Inform. 2021 Jul;28(1):
pubmed: 34326160
Med Image Anal. 2021 Feb;68:101914
pubmed: 33285479
Gastroenterology. 2020 Jan;158(1):76-94.e2
pubmed: 31593701
J Hepatol. 2022 Jul;77(1):116-127
pubmed: 35143898
World J Gastroenterol. 2021 Apr 28;27(16):1664-1690
pubmed: 33967550
Comput Biol Med. 2020 Aug;123:103836
pubmed: 32658781
Comput Methods Programs Biomed. 2020 Oct;195:105614
pubmed: 32650090
Front Oncol. 2020 Aug 20;10:1559
pubmed: 33014803
BMC Med. 2019 Jul 17;17(1):143
pubmed: 31311603
Cancers (Basel). 2020 Dec 07;12(12):
pubmed: 33297357
J Gastroenterol Hepatol. 2021 Mar;36(3):569-580
pubmed: 33709606
Sci Rep. 2015 Aug 11;5:12962
pubmed: 26260921
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2081-2090.e9
pubmed: 31887451
Sensors (Basel). 2020 Dec 10;20(24):
pubmed: 33321713
Int J Med Inform. 2021 Sep;153:104510
pubmed: 34108105
Hepatol Int. 2022 Jun;16(3):590-602
pubmed: 35349075
Korean J Radiol. 2020 Apr;21(4):387-401
pubmed: 32193887
J Med Imaging (Bellingham). 2020 Jan;7(1):012706
pubmed: 34541020

Auteurs

Pierre Allaume (P)

Department of Pathology CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.

Noémie Rabilloud (N)

Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.

Bruno Turlin (B)

Department of Pathology CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.
Research Unit n°UMR1341 NuMeCan-Nutrition, Métabolismes et Cancer, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.

Edouard Bardou-Jacquet (E)

Research Unit n°UMR1341 NuMeCan-Nutrition, Métabolismes et Cancer, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.
Department of Liver Diseases CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.

Olivier Loréal (O)

Research Unit n°UMR1341 NuMeCan-Nutrition, Métabolismes et Cancer, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.

Julien Calderaro (J)

Assistance Publique-Hôpitaux de Paris, Department of Pathology Henri Mondor, 94000 Créteil, France.
INSERM U955, Team Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers, 94000 Créteil, France.

Zine-Eddine Khene (ZE)

Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.
Department of Urology, CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.

Oscar Acosta (O)

Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.

Renaud De Crevoisier (R)

Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.
Department of Radiotherapy, Centre Eugène Marquis, 35033 Rennes, France.

Nathalie Rioux-Leclercq (N)

Department of Pathology CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.

Thierry Pecot (T)

Biosit Platform UAR 3480 CNRS US18 INSERM U955, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.

Solène-Florence Kammerer-Jacquet (SF)

Department of Pathology CHU de Rennes, Rennes 1 University, Pontchaillou Hospital, 2 rue Henri Le Guilloux, CEDEX 09, 35033 Rennes, France.
Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes 1 University, Pontchaillou Hospital, 35033 Rennes, France.

Classifications MeSH